[go: up one dir, main page]

DE69702911D1 - Oxydierte oligosaccharide - Google Patents

Oxydierte oligosaccharide

Info

Publication number
DE69702911D1
DE69702911D1 DE69702911T DE69702911T DE69702911D1 DE 69702911 D1 DE69702911 D1 DE 69702911D1 DE 69702911 T DE69702911 T DE 69702911T DE 69702911 T DE69702911 T DE 69702911T DE 69702911 D1 DE69702911 D1 DE 69702911D1
Authority
DE
Germany
Prior art keywords
oxydated
oligosaccharid
oligosaccharides
oxidized
orc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69702911T
Other languages
English (en)
Other versions
DE69702911T2 (de
Inventor
Wilson Harvey
Lowell Saferstein
David Wiseman
William Watt
Nicholas Light
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Medical Ltd
Original Assignee
Johnson and Johnson Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Medical Ltd filed Critical Johnson and Johnson Medical Ltd
Publication of DE69702911D1 publication Critical patent/DE69702911D1/de
Application granted granted Critical
Publication of DE69702911T2 publication Critical patent/DE69702911T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
    • C08B15/04—Carboxycellulose, e.g. prepared by oxidation with nitrogen dioxide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G3/00—Glycosides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/20—Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
DE69702911T 1996-06-28 1997-06-27 Oxydierte oligosaccharide Expired - Lifetime DE69702911T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9613683A GB2314840B (en) 1996-06-28 1996-06-28 Oxidized oligosaccharides and pharmaceutical compositions
PCT/GB1997/001726 WO1998000446A1 (en) 1996-06-28 1997-06-27 Oxidized oligosaccharides

Publications (2)

Publication Number Publication Date
DE69702911D1 true DE69702911D1 (de) 2000-09-28
DE69702911T2 DE69702911T2 (de) 2001-02-22

Family

ID=10796095

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69702911T Expired - Lifetime DE69702911T2 (de) 1996-06-28 1997-06-27 Oxydierte oligosaccharide

Country Status (16)

Country Link
EP (1) EP0907664B1 (de)
JP (2) JP4302187B2 (de)
KR (1) KR20000022286A (de)
AT (1) ATE195742T1 (de)
AU (1) AU725296B2 (de)
BR (1) BR9710003A (de)
CA (1) CA2258849C (de)
CZ (1) CZ294839B6 (de)
DE (1) DE69702911T2 (de)
ES (1) ES2148991T3 (de)
GB (1) GB2314840B (de)
GR (1) GR3034853T3 (de)
HU (1) HUP9903404A3 (de)
PL (1) PL189194B1 (de)
PT (1) PT907664E (de)
WO (1) WO1998000446A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7112320B1 (en) 1995-06-07 2006-09-26 Andre Beaulieu Solid wound healing formulations containing fibronectin
GB2344519B (en) * 1998-12-07 2004-05-19 Johnson & Johnson Medical Ltd Sterile therapeutic compositions
GB9900150D0 (en) 1999-01-05 1999-02-24 Unilever Plc Treatment for fabrics
GB2354708B (en) * 1999-10-01 2004-06-02 Johnson & Johnson Medical Ltd Compositions for the treatment of wound contracture
AU784607B2 (en) * 2000-05-12 2006-05-11 Systagenix Wound Management Ip Co. B.V. Free radical scavenging compositions
AU782756B2 (en) * 2000-05-12 2005-08-25 Systagenix Wound Management Ip Co. B.V. Solid composition exhibiting selective binding to dissolved iron
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
US7262181B2 (en) * 2001-04-30 2007-08-28 Beijing Textile Research Institute Water soluble cellulose etherified derivatives styptic materials
US20030118651A1 (en) * 2001-12-21 2003-06-26 Jampani Hanuman B. Bio-compatible means for controlled drug delivery to tissue and method of use
US20030124087A1 (en) * 2001-12-26 2003-07-03 Amitie Co. Ltd. Anti-adhesion barrier
US7252837B2 (en) 2002-06-28 2007-08-07 Ethicon, Inc. Hemostatic wound dressing and method of making same
US7279177B2 (en) 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
US20040101547A1 (en) * 2002-11-26 2004-05-27 Pendharkar Sanyog Manohar Wound dressing containing aldehyde-modified regenerated polysaccharide
GB2392913B (en) * 2002-09-11 2007-04-04 Johnson & Johnson Medical Ltd Wound dressings comprising complexes of oxidised celluloses with silver
PL207044B1 (pl) * 2002-09-11 2010-10-29 Johnson & Johnson Medical Ltd Materiał opatrunkowy na rany zawierający kompleks utlenionej celulozy ze srebrem, opatrunek zawierający ten materiał, oraz zastosowanie kompleksu do wytwarzania materiału opatrunkowego
GB2393120A (en) * 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
US8685943B2 (en) 2003-03-12 2014-04-01 Hill's Pet Nutrition, Inc. Methods for reducing diarrhea in a companion animal
US7019191B2 (en) 2003-03-25 2006-03-28 Ethicon, Inc. Hemostatic wound dressings and methods of making same
DE10319808A1 (de) * 2003-04-28 2004-11-18 Friedrich-Schiller-Universität Jena Verwendung von Polysaccharid-Derivaten als Mittel zur Stimulierung der Zellproliferation
GB2408206B (en) 2003-11-18 2007-11-28 Johnson & Johnson Medical Ltd Antioxidant and antimicrobial wound dressing materials
US20040265371A1 (en) 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
JP5122821B2 (ja) 2003-11-28 2013-01-16 イーストマン ケミカル カンパニー セルロースインターポリマー及び酸化方法
JP2008513153A (ja) * 2004-09-17 2008-05-01 デイビッド・エム・ディクソン 創傷治療用ドレッシング材及びその使用方法
CN101137402B (zh) 2004-10-20 2012-01-11 伊西康公司 供医疗装置用的加固可吸收多层织物及其制备方法
US9358318B2 (en) 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
EP2052746B1 (de) 2004-10-20 2014-11-26 Ethicon, Inc. Verfahren zum Herstellen eines hämostatischen Wundverbands
EP1919959B1 (de) * 2005-09-02 2016-10-26 Hemcon Medical Technologies (IP) Limited Verfahren zur herstellung von polyanhydroglucuronsäure und/oder deren salzen
JP4975996B2 (ja) * 2005-09-30 2012-07-11 東邦化学工業株式会社 カチオン変性ペクチン及び該物質を含む化粧料組成物
GB2444232A (en) 2006-11-30 2008-06-04 Ethicon Inc Wound dressing compositions comprising cell lysates
US20090074837A1 (en) * 2007-09-19 2009-03-19 Ut-Battelle, Llc Bioresorbable Calcium-Deficient Hydroxyapatite Hydrogel Composite
US9376648B2 (en) 2008-04-07 2016-06-28 The Procter & Gamble Company Foam manipulation compositions containing fine particles
JP2010284216A (ja) * 2009-06-09 2010-12-24 Hogi Medical:Kk カルボキシメチルセルロース構造体及びその製造方法
JP5818055B2 (ja) * 2010-03-17 2015-11-18 静岡県公立大学法人 トリアセチルセルロースブロック共重合体、その中間体、充填剤、および、界面活性剤
EP2692739B1 (de) * 2011-03-30 2019-07-03 Nippon Paper Industries Co., Ltd. Verfahren zur herstellung von zellulosenanofasern
DE102011007528A1 (de) * 2011-04-15 2012-10-18 Aesculap Aktiengesellschaft Thixotrope Zusammensetzung, insbesondere zur postchirurgischen Adhäsionsprophylaxe
WO2012171725A2 (en) * 2011-06-16 2012-12-20 Unilever Plc Aqueous gels
CN104945448B (zh) * 2015-05-22 2018-06-19 上海绿谷制药有限公司 一种氧化型β-1,4-寡聚葡萄糖醛酸及其制备方法和用途
JP2019519619A (ja) * 2016-06-02 2019-07-11 グンゼ株式会社 医療用繊維構造物及び医療用積層体
KR102294257B1 (ko) * 2019-04-30 2021-08-26 한양대학교 에리카산학협력단 바이오셀룰로오스-펩티드 복합체 및 이의 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE360128C (de) * 1921-01-03 1922-09-29 Albert Reychler Dr Verfahren zur Herstellung von Staerkeloesungen
US2517772A (en) * 1945-05-11 1950-08-08 Parke Davis & Co Neutralized oxidized cellulose products
US3598622A (en) * 1969-02-19 1971-08-10 Cpc International Inc Alkali treated starch compositions
AR243204A1 (es) * 1986-11-21 1993-07-30 Ajorca Sa Un metodo para la depolimerizacion quimica de polisacaridos.
CA2033046C (en) * 1990-01-12 1999-08-03 Lowell Saferstein Process for preparing a neutralized oxidized cellulose product and its method of use
CN1035803C (zh) * 1990-07-24 1997-09-10 中国化工进出口总公司 可溶性止血织物
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
JP3357996B2 (ja) * 1993-03-26 2002-12-16 ライオン株式会社 金属イオン封鎖性オリゴマー化合物の製造方法及びそのオリゴマー化合物を含む洗浄剤組成物
US5414079A (en) * 1993-08-03 1995-05-09 Biocontrol Incorporated Oxidized cellulose
DE4411681A1 (de) * 1994-04-05 1995-10-12 Hoechst Ag Verfahren zur Herstellung niedermolekularer Polysaccharidether

Also Published As

Publication number Publication date
EP0907664B1 (de) 2000-08-23
CZ427498A3 (cs) 1999-05-12
HUP9903404A2 (hu) 2000-03-28
HUP9903404A3 (en) 2001-03-28
PT907664E (pt) 2000-12-29
GB9613683D0 (en) 1996-08-28
JP5208707B2 (ja) 2013-06-12
GR3034853T3 (en) 2001-02-28
JP2009102645A (ja) 2009-05-14
CA2258849C (en) 2008-01-22
CZ294839B6 (cs) 2005-03-16
GB2314840A (en) 1998-01-14
AU725296B2 (en) 2000-10-12
BR9710003A (pt) 2000-01-11
DE69702911T2 (de) 2001-02-22
AU3269397A (en) 1998-01-21
CA2258849A1 (en) 1998-01-08
ES2148991T3 (es) 2000-10-16
WO1998000446A1 (en) 1998-01-08
EP0907664A1 (de) 1999-04-14
PL330825A1 (en) 1999-06-07
JP2000514110A (ja) 2000-10-24
ATE195742T1 (de) 2000-09-15
KR20000022286A (ko) 2000-04-25
JP4302187B2 (ja) 2009-07-22
PL189194B1 (pl) 2005-07-29
GB2314840B (en) 2000-09-06

Similar Documents

Publication Publication Date Title
DE69702911D1 (de) Oxydierte oligosaccharide
AU4162400A (en) Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii
FI940738A0 (fi) Elektroneja johtavia molekyylivalmisteita
ES2101499T3 (es) Fibras.
BR9808491A (pt) Compostos calcilìticos
HUT77049A (hu) Katepszin-02-fehérjék, -nukleinsavak és -ellenanyagok
BR9711117A (pt) Oligossacarídios modificados.
WO1998004582A8 (en) Isolated peptides derived from mage-2
ATE142888T1 (de) Antigen-wirkende proteine von borrelia burgdorferi
NO965142L (no) Betaarkdannende peptider og geler fremstilt av disse
EP0750679A4 (de) Isolierte von tyrosinase abgeleitete peptide und ihre verwendung
DE69120390D1 (de) Kollagen-bindendes protein sowie dessen herstellung
FI964227L (fi) Hepariinia sitova proteiini verenmyrkytyksen hoitoon ja menetelmät sen valmistamiseksi
EP0737073A4 (de) Peptide, die dem antikoagulierenden Effekt von Heparin oder vonHeparin mitgeringen Molekulargewicht umkehren
BR9813465A (pt) Polissacarìdeos modificados que exibem reconhecimento biológico alterado
DE69623700D1 (de) Turbomolekularpumpe
NO930234L (no) Antikoagulerende midler
NO20020329L (no) Antitumor-antistoffer, proteiner og anvendelse derav
ATE291415T1 (de) Kollagenfreie kosmetische zubereitungen aus vernetzten chitosan hydrogelen hergestellt
NO972531L (no) Nye membranproteiner p76 av Helicobacter pylori
PT751775E (pt) Derivados de mercaptoacetilamida hipocolesterolemicos, antiateroscleroticos e hipotrigliceridemicos
DE69613793D1 (de) Ophthalmische Cromolyn-Gelzubereitung
DE69701943D1 (de) Zusammensetzungen auf Basis von ABS Polymerisat
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
SE9604439D0 (sv) New receptor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN